Skip to main content

Axogen

Axogen Inc is a medical technology company focused on the development and commercialization of proprietary surgical solutions for peripheral nerve repair and regeneration. The company provides a comprehensive portfolio of nerve repair products, including Avance Nerve Graft, Avive Soft Tissue Membrane, and AxoGuard Nerve Connector, utilized by surgeons in treating traumatic nerve injuries and chronic neuropathies. Its core operations encompass biomedical tissue processing, surgical device manufacturing, clinical research, and medical product distribution. Revenue is derived primarily from the direct sale of specialized nerve repair biological grafts and surgical accessories to hospitals and ambulatory surgery centers. Axogen holds a leading market position in surgical peripheral nerve reconstruction solutions. The company is headquartered in Alachua, Florida, United States, and its common stock trades on the Nasdaq Global Select Market.

6 of the funds FundTelligence covers report a position in Axogen.

Sector
Health Care
Country
United States
Funds holding it
6

Funds holding Axogen

Loading...